Stay updated on EMPA Acute Heart Failure Improv Trial

Sign up to get notified when there's something new on the EMPA Acute Heart Failure Improv Trial page.
Latest website image capture
Clouds background image

Latest updates to the EMPA Acute Heart Failure Improv Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:36:14.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 on the webpage has recently changed to 8, indicating a potential update or revision in the data related to the treatment of patients with acute heart failure using Empagliflozin or placebo in a clinical trial setting.
    Difference
    0.1%
    Check dated 2024-06-06T14:31:22.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The webpage has updated the 'Participation Criteria' section to provide detailed eligibility criteria for study participants, including age, health conditions, and prior treatments, replacing the previous 'No information provided' note.
    Difference
    25%
    Check dated 2024-05-22T21:10:51.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:23:40.000Z thumbnail image

Stay in the know with updates to EMPA Acute Heart Failure Improv Trial

Enter your email address, and we'll notify you when there's something new on the EMPA Acute Heart Failure Improv Trial page.